Tweet
Fascinating article in NYT Sunday. I see what you like here Mr Huge. http://www.nytimes.com/2012/12/30/bu...pagewanted=all
-
-
Nice find Babe.Originally posted by riverbabe View Post=============================
I am HUGE! Bring me your finest meats and cheeses.
- $$$MR. MARKET$$$Comment
-
My patience is being very dearly rewarded!=============================
I am HUGE! Bring me your finest meats and cheeses.
- $$$MR. MARKET$$$Comment
-
-
It is hard to find the Truth when you start your search with a preconceived notion of what the Truth will be.Comment
-
Questcor Stock Delivers Big Growth And Income
2 Comments
By VINCENT MAO, INVESTOR'S BUSINESS DAILY
Posted 05/03/2013 06:03 PM ET
Email Print License Comment
inShare
Questcor Pharmaceuticals (QCOR) is not your typical income stock. Its shares have been volatile, but the company has produced big growth and a large dividend yield.
The Anaheim, Calif.-based firm is best known for its Acthar Gel, used to treat about 19 conditions including multiple sclerosis, infantile spasms and nephrotic syndrome. Acthar accounts for nearly all of the company's revenue, which can be risky. But Questcor is seeking new applications for Acthar.
Questcor's earnings and sales fell in 2009, but they've grown by double or triple digits since. Last year, profit surged 162% and sales bolted 133%. Both marked the best performance in years. Questcor has a three-year Earnings Stability Factor of 14, a good score that was hurt by the drop in 2009. Its three-year sales growth rate is a solid 93%.
Last week, the company reported Q1 earnings that rose 25% to 76 cents a share. Sales grew 41% to $135.1 million. Both marked a sharp slowdown from recent periods and missed expectations. Distribution-channel issues and lower prescriptions for MS flare-ups hurt revenue.
The company, however, said that shipments of Acthar in April and prescriptions signaled a comeback.
Questcor started paying a dividend in the third quarter of 2012. The firm currently pays 25 cents a share per quarter, or $1 a share annually, for an annualized yield of about 3%. Its yield is about at the middle among other dividend-paying stocks in IBD's Medical-Ethical Drugs industry group.
Last fall, Questcor got hit hard after Citron Research said health insurer Aetna (AET) revised its opinion of Acthar. News of a government probe into its promotional practices didn't help shares either. But the stock has been recovering steadily.
Read More At Investor's Business Daily: http://news.investors.com/investing-...#ixzz2UAHsOoDd
Follow us: @IBDinvestors on Twitter | InvestorsBusinessDaily on Facebook=============================
I am HUGE! Bring me your finest meats and cheeses.
- $$$MR. MARKET$$$Comment
-
=============================
I am HUGE! Bring me your finest meats and cheeses.
- $$$MR. MARKET$$$Comment
-
Gotta hand it to 'ya. Must be the luck of the Irish. (P.S. I don't consider myself a b!)Comment
-
Wow, QCOR is back over $50 now... quite an impressive comeback here. Wish I'd had the guts to hang onto some of my $19 shares, but anyway, looks like we'll have another $$MM winner and a new pick to ride very soon...Originally posted by jiesen View PostComment
-
QCOR is up 178% since September 24, 2012. That's a pretty good place to tie up my capital..don't you think?Originally posted by Deaddog View Post=============================
I am HUGE! Bring me your finest meats and cheeses.
- $$$MR. MARKET$$$Comment
-
shoot, maybe I should have just gotten some at $51 today, even. AH trading took this one to $59.5, which is above the 15% target! looks like it'll be another winner to cash in tomorrow for $$MM...Originally posted by jiesen View PostComment
-
you seeeeeeeeeeeeeeeeeeeeees?=============================
I am HUGE! Bring me your finest meats and cheeses.
- $$$MR. MARKET$$$Comment
-
-
holy crap, look at that sucker go!Comment
-
Comment